KR920004366A - 6,7-디하이드로-3-페닐-1,2-벤즈이속사졸-4(5h)-온 및-올, 이들의 제조방법 및 약제로서 이들의 용도 - Google Patents

6,7-디하이드로-3-페닐-1,2-벤즈이속사졸-4(5h)-온 및-올, 이들의 제조방법 및 약제로서 이들의 용도 Download PDF

Info

Publication number
KR920004366A
KR920004366A KR1019910014488A KR910014488A KR920004366A KR 920004366 A KR920004366 A KR 920004366A KR 1019910014488 A KR1019910014488 A KR 1019910014488A KR 910014488 A KR910014488 A KR 910014488A KR 920004366 A KR920004366 A KR 920004366A
Authority
KR
South Korea
Prior art keywords
hydrogen
lower alkyl
compound
general formula
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1019910014488A
Other languages
English (en)
Other versions
KR0173685B1 (ko
Inventor
고든 웻틀로퍼 데이빗
마이클 슈츠크 그레고리
앨렌 네모토 피터
Original Assignee
제이 티. 쉐크, 쥬니어
훽스트-럿셀 파마슈티칼즈 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제이 티. 쉐크, 쥬니어, 훽스트-럿셀 파마슈티칼즈 인코포레이티드 filed Critical 제이 티. 쉐크, 쥬니어
Publication of KR920004366A publication Critical patent/KR920004366A/ko
Application granted granted Critical
Publication of KR0173685B1 publication Critical patent/KR0173685B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

내용 없음

Description

6,7-디하이드로-3-페닐-1,2-벤즈이속사졸-4(5H)-온 및-올, 이들의 제조방법및 약제로서 이들의 용도
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (11)

  1. 일반식(I)의 화합물 또는 이의 약제학적으로 허용되는 산부가염 및 해당되는 경우 이들의 기하 이성체 및 광학 이성체 및 라세미체 혼합물.
    상기식에서,X는또는 저급알킬이고;Y는 수소,할로겐,저급알킬,저급알콕시,트리플루오로메틸, 니트로 또는 아미노이며;R은 문제의 산소원자와 탄소원자간의 결합이 단일 결합일 때 H이며;점선은 산소 원자에 대한 이중결합 부분이며;R1은수소, 저급알킬 또는 아릴 저급알킬이며;R2및 R3는 독립적으로 수소, 저급알킬 또는 아릴 저급알킬이거나, R2와 R3가 질소원자와 함께 피페리디닐, 피롤리디닐, 모르폴리닐, 이미다졸-1-일 및 1-피페라지닐로 이루어진 그룹 중에서 선택된 임의로 치환된 헤테로사이클(여기에서, 치환체는 수소 또는 저급알킬이다);
    일반식(여기에서, R6는 저급알킬, 아릴, 아릴저급알킬, 2-피리미열,일반식의 2-피리디닐 또는 일반식의 4-피리디닐이다)의 4-치환된-1-피페라지닐;일반식(여기에서, R7은 수소, 저급알킬, 아릴, 아릴저급알킬, 일반식의 2-피리디닐, 일반식의 4-피리디닐, 일반식의 2-피리
    미디닐, 아릴카보닐,또는이고 R8은 수소 또는 -OH이다)의 4-치환된-1-피페리디닐을 형성하며;R4는 수소, 저급알콕시카보닐 또는 아릴옥시카보닐이며;Z는 염소, 브롬 또는 불소이며;m 및 n은 각각 1 내지 4의 정수이다.
  2. 제1항에 있어서, 일반식(Ia)의 화합물 또는 이의 약제학적으로 허용되는 산부가염 및 해당되는 경우 이들의 기하 이성체 및 광학 이성체 및 라세미체혼합물.
    상기식에서, X는(여기에서 Y는 수소 또는 할로겐이고 n은 1이다)이고,R1은 수소이며;R2및 R3는 독립적으로 저급알킬이거나, R2와 R3가 질소원자와 함께 피페리디닐, 피롤리디닐, 모르폴리닐, 이미다졸-1-일 및 1-피페라지닐로 이루어진 그룹중에서 선택된 임의로 치환된 헤테로사이클(여기에서, 치환체는 수소 또는 저급알킬이다)을 형성하거나;R2및 R3가 질소원자와 함께 일반식(여기에서, R6는 저급알킬, 아릴, 2-피리미딜, 2-피리디닐이거나 일반식의 그룹이다)의 4-치환된 1-피페라지닐을 형성하거나 R2및 R3가 질소원자와 함께 일반식
    (여기에서, R7은 아릴, 아릴카보닐이거나 일반식
    의 그룹이고 R8,은 수소 또는 OH이다)의 4-치환된 1-피페리디닐을 형성하며;R4는수소 또는 저급알콕시카보닐이며;Z는 수소 또는 염소이며;m은 1 내지 3의 정수이며 n은 1이다.
  3. 제2항에 있어서, Y가 불소이고 R2및 R3가 질소원자와 함께 4-치환된 1-피페라지닐 또는 4-치환된 1-피페리디닐이며 R4가 수소이며 m이 3인 화합물.
  4. 제1항에 있어서, 6,7-디하이드로-5-[3-(4-(4-플루오로페닐)-1-피페라지닐)-프로필]-3-페닐-1,2-벤즈이속사졸-4(5H)-온 또는 이의 약제학적으로 허용되는 산부가염인 화합물.
  5. 제1항에 있어서, 6,7-디하이드로-5-[3-(4-(4-플루오로벱조일)1-피페리디닐)-프로필]-3-(2-플루오로페닐)-1,2-벤즈이속사졸-4(5H)-온 또는 이의 약제학적으로 허용되는 산부가염인 화합물.
  6. 제1항에 있어서, 6,7-디하이드로-5-[3-(4-(4-플루오로벤질)-프로필]-3-(4-플루오로페닐)-1, 2-(벤즈이속사졸-4(5H)-온 또는 이의 약제학적으로 허용되는 산부가염인 화합물.
  7. 제1항에 있어서, 6,7-디하이드로-5-[3-(4-(4-플루오로벤조일)-1-피페리디닐)-프로필]-3-(3-플루오로페닐)-1,2-벤즈이속사졸-4(5H)-온 또는 이의 약제학적으로 허용되는 산부가염인 화합물.
  8. 제1항에 있어서, 6,7-디하이드로-5-[3-(4-(4-플루오로벤조일)-1-피페리디닐)-프로필]-3-페닐-1,2-벤즈이속사졸-4-(5H)-온 또는 이의 약제학적으로 허용되는 산부가염인 화합물.
  9. 활성 성분으로서 제1항에 따른 화합물 및 이에 대한 적합한 담체를 함유함을 특징으로 하는 약제학적 조성물.
  10. 정신병 억제 활성 및/또는 전통 활성이 있는 약제를 제조하기 위한 제1항에 따른 화합물의 용도.
  11. a)일반식
    (여기에서, X는 (Y)n이고 Y및 n은 제1항에서 정의한 바와 같다)의 화합물을 일반식(Ⅶ) (여기에서, R2및 R3는 제1항에서 정의한 바와 같다)아민과파라포름알데하이드의 존재하에서 반응시키거나, 일반식(Ⅶ)의 아민과 강 유기산의 존재하에서 반응시켜 일반식
    (여기에서, X, R2,및 R3는 전술한 바와 같고, R1및 R4는 각각 수소이며 m은 1이다)의 화합물을 형성시키거나,
    b)일반식
    (여기에서, X및 m은 전술한 바와 같고 R1은 수소 또는 저급알킬이며 R4및 수소, 저급알콕시 카보닐 또는 아릴옥시 카보닐이며 Hal은 Cl,F,Br또는 I이다)의 화합물을 일반식(Ⅶ)의 아민과 반응시켜 X,R1,R2,R3,R4및 m이 전술한 바와 같은 일반식(Ia)의 화합물을 형성시키고, c)R2및 R3가 독립적으로 수소,저급알킬 또는 아릴저급알킬인 일반식(Ia)의 화합물을 임의로피페리딘, 피롤리딘, 모르폴린, 1H-이미다졸, 1-피페라진, 4-치환된 1-피페라진 또는 4-치환된 1-피페리딘과 치환 반응시켜 R2및 R3가 질소원자와 함께 전술한 헤테로사이클을 형성하는 일반식(Ia)의 화합물을 형성시키며,
    d)일반식
    (여기에서, X,R1,R2,R3및 m은 전술한 바와 같고 R4는 수소이다)의 화합물을 임의로 환원시켜 일반식
    (여기에서, X,R1,R2,R3및 m은 전술한 바와 같다)의 화합물을 형성시킴을 특징으로 하여, 제1항에 따른 화합물을 제조하는 방법.
    ※ 참고사항 :최초출원 내용에 의하여 공개하는 것임.
KR1019910014488A 1990-08-23 1991-08-22 6.7-디하이드로-3-페닐-1,2-벤즈이속사졸-4(5h)-온 및-올, 이의 제조방법 및 이를 함유하는 약제학적 조성물 Expired - Fee Related KR0173685B1 (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US57148290A 1990-08-23 1990-08-23
US571,482 1990-08-23
US07/571,482 1990-08-23
US692341 1991-04-26
US692,341 1991-04-26
US07/692,341 US5114936A (en) 1990-08-23 1991-04-26 6,7-dihydro-3-phenyl-1,2-benzisoxazol-4(5h)-ones and -ols, compositions and pharmaceutical use

Publications (2)

Publication Number Publication Date
KR920004366A true KR920004366A (ko) 1992-03-27
KR0173685B1 KR0173685B1 (ko) 1999-02-01

Family

ID=27075593

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910014488A Expired - Fee Related KR0173685B1 (ko) 1990-08-23 1991-08-22 6.7-디하이드로-3-페닐-1,2-벤즈이속사졸-4(5h)-온 및-올, 이의 제조방법 및 이를 함유하는 약제학적 조성물

Country Status (20)

Country Link
US (1) US5114936A (ko)
EP (1) EP0474012B1 (ko)
JP (1) JP3018619B2 (ko)
KR (1) KR0173685B1 (ko)
AT (1) ATE145644T1 (ko)
AU (1) AU634944B2 (ko)
CA (1) CA2049733C (ko)
CS (1) CS260191A3 (ko)
DE (1) DE69123315T2 (ko)
DK (1) DK0474012T3 (ko)
ES (1) ES2095277T3 (ko)
FI (1) FI913957A7 (ko)
GR (1) GR3022697T3 (ko)
HU (1) HU215439B (ko)
IE (1) IE76138B1 (ko)
IL (1) IL99264A (ko)
NO (1) NO913292L (ko)
NZ (1) NZ239494A (ko)
PT (1) PT98747B (ko)
YU (1) YU142991A (ko)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114960A (en) * 1989-07-20 1992-05-19 Hoffmann-La Roche Inc. Substituted isoxazole derivatives
US5143923B1 (en) * 1991-04-29 1993-11-02 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
US5225412A (en) * 1991-04-29 1993-07-06 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
GB2264299B (en) * 1992-02-19 1995-07-26 British Tech Group Iso-oxazolidine derivatives
GB9226857D0 (en) * 1992-12-23 1993-02-17 Boyd Edward A Pharmaceutical compositions
GB2284600A (en) * 1994-01-21 1995-06-14 Shell Int Research Herbicidal 3-(hetero)aryl-4-acylisoxazole compositions and compounds
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
US7253165B2 (en) * 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
HUP0202706A3 (en) * 1999-09-14 2004-12-28 Aventis Pharmaceuticals Inc Br Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists, their intermediates, process for their preparation and pharmaceutical compositions containing them
WO2003076419A1 (en) 2002-03-08 2003-09-18 Japan Science And Technology Agency Isoxazole derivatives and process for producing the same
US6770659B2 (en) 2002-08-26 2004-08-03 Sk Corporation Benzoyl piperidine compounds
EP1997371A4 (en) 2006-03-22 2010-03-03 Tominaga Jyushi Kogyosho Kk OVERFLOW DEVICE FOR WATER TANK
US8132534B2 (en) 2006-08-25 2012-03-13 Kabushiki Kaisha Tominaga Jyushi Kogyosho Overflow device for water tank
US8957206B2 (en) * 2012-09-14 2015-02-17 Supernus Pharmaceuticals Inc. Methods of producing molindone and its salts
US10745401B2 (en) 2018-07-23 2020-08-18 Sumitomo Dainippon Pharma Co., Ltd. Condensed lactam derivative
CA3105428A1 (en) 2018-07-23 2020-01-30 Sumitomo Dainippon Pharma Co., Ltd. Condensed lactam derivative
WO2023083445A1 (en) 2021-11-10 2023-05-19 Symrise Ag Compositions comprising trpm8 agonistic cooling agents

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4010176A (en) * 1972-10-27 1977-03-01 Merck & Co., Inc. Isoxazole substituted nitroimidazoles
US4217349A (en) * 1974-07-01 1980-08-12 Sumitomo Chemical Company, Limited Benzisoxazole derivatives
US4156005A (en) * 1978-06-21 1979-05-22 Merck & Co., Inc. Derivatives of 1,2-benzisoxazoles
GB2024008B (en) * 1978-06-28 1983-02-16 Merck & Co Inc Compositions for treating trypanosomiasis infections
FI821415A7 (fi) * 1981-04-27 1982-10-28 Hoechst Roussel Pharma 1-/3-(6-fluoro-1,2-bensisoksatsoli-3- yyli)propyyli/-4-hydroksi-4-fenyylipiperidiinejä, menetelmä ja välituovälituotteita niiden valmistamiseksi ja niiden käyttö lääkeaineina.
US4458075A (en) * 1982-04-09 1984-07-03 Hoechst-Roussel Pharmaceuticals Inc. 6-Fluoro-3-[3-(1-heterocyclo)propyl]-1,2-benzisoxazoles
IL66866A (en) * 1982-04-09 1987-08-31 Hoechst Roussel Pharma 1-(3-(6-fluoro-1,2-benzisoxazol-3-yl)propyl)-4-(substituted)-piperazines and-piperidines,a process for the preparation thereof,and pharmaceutical compositions containing them
DE3586794T2 (de) * 1984-12-21 1993-05-27 Duphar Int Res Arzneimittel mit psychotroper wirkung.
HU206109B (en) * 1987-10-26 1992-08-28 Pfizer Process for producing heterocyclic carbonylpropyl pyrimidinyl piperazine derivatives and pharmaceutical compositions comprising same
US5114960A (en) * 1989-07-20 1992-05-19 Hoffmann-La Roche Inc. Substituted isoxazole derivatives

Also Published As

Publication number Publication date
EP0474012B1 (en) 1996-11-27
EP0474012A1 (en) 1992-03-11
JP3018619B2 (ja) 2000-03-13
YU142991A (sh) 1995-01-31
IE912976A1 (en) 1992-02-26
CA2049733C (en) 2003-10-21
FI913957A0 (fi) 1991-08-21
GR3022697T3 (en) 1997-05-31
PT98747A (pt) 1992-07-31
IE76138B1 (en) 1997-10-08
DK0474012T3 (da) 1997-05-12
IL99264A (en) 1996-01-19
JPH04230673A (ja) 1992-08-19
US5114936A (en) 1992-05-19
NZ239494A (en) 1994-08-26
FI913957L (fi) 1992-02-24
CA2049733A1 (en) 1992-02-24
ATE145644T1 (de) 1996-12-15
DE69123315D1 (de) 1997-01-09
AU8261791A (en) 1991-11-07
PT98747B (pt) 1999-01-29
DE69123315T2 (de) 1997-05-22
HU215439B (hu) 1999-09-28
ES2095277T3 (es) 1997-02-16
FI913957A7 (fi) 1992-02-24
AU634944B2 (en) 1993-03-04
KR0173685B1 (ko) 1999-02-01
CS260191A3 (en) 1992-04-15
HUT61533A (en) 1993-01-28
NO913292L (no) 1992-02-24
NO913292D0 (no) 1991-08-22
IL99264A0 (en) 1992-07-15
HU912756D0 (en) 1992-01-28

Similar Documents

Publication Publication Date Title
RU2354653C2 (ru) Производные 1-(2-аминобензол)пиперазина, используемые в качестве ингибиторов поглощения глицина и предназначенные для лечения психоза
RU2355683C2 (ru) Производные 1-бензоилпиперазина в качестве ингибиторов поглощения глицина для лечения психозов
KR920005113B1 (ko) 정신병치료제 1-플루오로페닐부틸-4-(2-피리미디닐)피페라진 유도체의 제조방법.
CA2095826A1 (en) 4-arylpiperazines and 4-arylpiperidines
KR880011123A (ko) N- 벤즈히드릴- 치환된 헤테로사이클 유도체, 그의 제조방법
US6852718B2 (en) Phenylsulphonylipiperazinyl derivatives as 5-HT receptor ligands
CY1837A (en) 4-(4-(4-(4-((2-(2 4-Difluorophenyl)-2-(1h-azolylmethyl) -1,3-dioxolan-4-yl) -methoxy)phenyl) - 1 -piperazinyl) phenyl)triazolones
DK170472B1 (da) Aminoalkylthioderivater af triazolopyridin eller triazoloquinolin og syreadditionssalte deraf samt deres fremstilling og farmaceutisk præparat og lægemiddel indeholdende dem
HUT61533A (en) Process for producing 6,7-dihydro-3-phenyl-1,2-benzisoxazole-4(5h)-one and -ol derivatives and pharmaceutical compositions comprising such derivatives as active ingredient
CA2417190A1 (en) New beta-amyloid inhibitors, processes for preparing them and their use as pharmaceutical compositions
JPH02184673A (ja) スルホンアミド化合物
US4556656A (en) 2-Benzoxepins
US3410851A (en) Derivatives of flavone
US4408049A (en) Substituted piperazinyl-1,2,4-triazoles
DK158514B (da) Analogifremgangsmaade til fremstilling af piperazinyl- eller homopiperazinylderivater
US3270004A (en) Disubstituted piperazines useful as schistosomiasis agents
JPH075579B2 (ja) アミノチアゾ−ル化合物
CA1127156A (en) Piperazine methanimine derivatives, process for their preparation and applications thereof
US2995553A (en) Substituted piperazines
IL42944A (en) Basically substituted benzene-1,3-disulfonamides and process for their manufacture
ES2004809A6 (es) Procedimiento de obtencion de nuevas 1-(2-(fenilmetil)fenil)piperazinas
US2777849A (en) 1, 1'-alkylenedipiperazines and methods of preparing same
US4247700A (en) 2-(Substitutedpiperidylmethyl)propene and propane nitriles
KR860002484A (ko) 방향족-1,4-옥스아제핀온 및 티온의 제조방법
JPH0588222B2 (ko)

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20031022

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20041101

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20041101